外周血分子可测量残留病足以识别即将临床复发的急性髓系白血病患者
该综述指出,治疗结束后纵向监测分子可测量残留病(MRD)有助于识别长期血液学完全缓解的急性髓系白血病(AML)患者的 imminent 复发。外周血月度MRD评估优于骨髓监测,能更好区分即将血液学复发者与长期缓解者,并可能支持抢先治疗。
要点
- 治疗结束后纵向分子MRD监测可识别AML imminent 复发。
- 外周血可作为MRD评估的替代来源,月度评估优于骨髓。
- 外周血MRD可支持抢先治疗策略以延迟或逆转白血病再生长。
核心结论
- 外周血分子MRD足以识别即将临床复发的AML患者,并可能允许抢先治疗。
研究设计与样本
- 本文为综述,总结治疗结束后纵向分子MRD监测在长期血液学完全缓解AML患者中的应用。
主要发现
- 在细胞形态学复发前追踪定量PCR MRD升高可触发个体化管理决策。
- 骨髓持续MRD阳性在核心结合因子白血病和NPM1突变AML中均常见。
- 外周血月度MRD评估优于骨髓,能更好区分即将血液学复发者与长期缓解者。
关键数值与推荐
- 当前欧洲白血病网(ELN)MRD推荐承认外周血可作为MRD评估的替代来源。
临床怎么用
- 对长期血液学完全缓解的AML患者,可考虑外周血月度分子MRD监测以识别 imminent 复发。
- 基于外周血MRD升高可个体化决定抢先治疗,以延迟或逆转白血病再生长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Longitudinal molecular measurable residual disease (MRD) sampling after completion of therapy serves as a refined tool for identification of imminent relapse of acute myeloid leukaemia (AML) among patients in long-term haematological complete remission. Tracking of increasing quantitative polymerase chain reaction MRD before cytomorphological reappearance of blasts may instigate individual management decisions and has paved the way for development of pre-emptive treatment strategies to substantially delay or perhaps even revert leukaemic regrowth. Traditionally, MRD monitoring is performed using repeated bone marrow aspirations, albeit the current European LeukemiaNet MRD recommendations acknowledge the use of peripheral blood as an alternative source for MRD assessment. Persistent MRD positivity in the bone marrow despite continuous morphological remission is frequent in both core binding factor leukaemias and nucleophosmin 1-mutated AML. In contrast, monthly assessment of MRD in peripheral blood superiorly separates patients with imminent haematological relapse from long-term remitters and may allow pre-emptive therapy of AML relapse.
引用
- Skou AS, Juul-Dam KL, Ommen HB, et al. Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse. Br J Haematol. 2021. PMID: 33851435. doi:10.1111/bjh.17449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。